Epirus Biopharmaceuticals' Merger

Epirus Biopharmaceuticals raised a round of funding on July 15, 2014. Investors include Zalicus.

Epirus is building a global biosimilar enterprise to improve patient access to important medicines. The Company's strategy for commercial success relies on targeted approaches for diverse global mark…

Articles about Epirus Biopharmaceuticals' Merger: